Article Information
History
- November 19, 2020.
Article Versions
- Version 1 (September 23, 2020 - 04:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Shengjie Li, MD1,2,
- Yichao Qiu, MD1,
- Li Tang, MD1,
- Zhujian Wang, MD1,
- Wenjun Cao, MD, PhD1,2,* and
- Xinghuai Sun, MD, PhD2
- 1Clinical Laboratory, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China
- 2Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China
- ↵*Corresponding author: Wenjun Cao, E-mail: wgkjyk{at}aliyun.com, Address: Eye & ENT Hospital, Shanghai Medical College, Fudan University, No.83 Fenyang Road, Shanghai, China, 200031
Posted November 19, 2020.
Seroprevalence of antibodies to SARS-CoV-2 is particularly high in patient population with ocular surface diseases
